Literature DB >> 6824557

Mianserin, maprotiline and the electroencephalogram.

E M Sedgwick, J G Edwards.   

Abstract

1 EEGs were recorded from patients with depressive illness before and after four weeks of treatment with mianserin, maprotiline or placebo. 2 Visual analysis of the records showed a small but statistically significant increase in frequency of beta activity in the mianserin group. 3 One subject taking maprotiline developed spike and wave discharges but had no convulsive seizures. 4 The findings do not support those of previous studies. It seems that changes seen in the EEG early after treatment are not sustained for four weeks.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824557      PMCID: PMC1427905          DOI: 10.1111/j.1365-2125.1983.tb05873.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  [Use of ludiomil in intravenous perfusions in the treatment of depressive states].

Authors:  T Lempérièr; A Féline; J Adès; C Pilate; A Gutmann
Journal:  Ann Med Psychol (Paris)       Date:  1975-11       Impact factor: 0.380

2.  Electroencephalogram study of mianserin in depressed patients.

Authors:  P Irwin; M Fink
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

3.  EEG, blood level, and behavioral effects of the antidepressant mianserin (ORG GB-94).

Authors:  M Fink; P Irwin; M Gastpar; J J DeRidder
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

4.  The double radio-isotope derivative technique for the assay of drugs in biological material. I. The determination of maprotiline.

Authors:  W Riess
Journal:  Anal Chim Acta       Date:  1974-02       Impact factor: 6.558

5.  EEG changes in treatment with maprotiline.

Authors:  J Misurec; K Náhunek; A Rodová
Journal:  Act Nerv Super (Praha)       Date:  1973-05

6.  The effect of compound CIBA 34,276-Ba on the cortical electro-encephalogram of healthy persons.

Authors:  U J Jovanović; B Tan-Eli
Journal:  Eur Neurol       Date:  1970       Impact factor: 1.710

7.  Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).

Authors:  T M Itil; N Polvan; W Hsu
Journal:  Curr Ther Res Clin Exp       Date:  1972-07

8.  Maprotiline (Ludiomil, Ciba 34,276-BA) and imipramine in depressed outpatients: a double-blind clinical study.

Authors:  A N Singh; B Saxena; M Gent; H L Nelson
Journal:  Curr Ther Res Clin Exp       Date:  1976-04

9.  Incidence and prognostic significance of "epileptiform" activity in the eeg of non-epileptic subjects.

Authors:  L Zivin; C A Marsan
Journal:  Brain       Date:  1968       Impact factor: 13.501

10.  Comparisons of maprotiline with imipramine in severe depression: a multicenter controlled trial.

Authors:  J N Logue; B A Sachais; J P Feighner
Journal:  J Clin Pharmacol       Date:  1979-01       Impact factor: 3.126

View more
  2 in total

Review 1.  Effects of psychotropic drugs on seizure threshold.

Authors:  Francesco Pisani; Giancarla Oteri; Cinzia Costa; Giorgio Di Raimondo; Raoul Di Perri
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report.

Authors:  J G Edwards; A Goldie
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.